ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Edesa Biotech, Inc. (EDSA)

NASDAQ

$1.20

$--

(0.00%)

Edesa Biotech, Inc. (EDSA) Live Price Chart

Page last updated: 2026-02-12 14:21:00

Key Market Data

Market Cap	$9.99M
Open	$1.07
High	$133.70
Low	$0.94
Previous Close	$1.07
Price Change	--
Percentage Change	0.00%
Volume	331

Edesa Biotech, Inc. (EDSA) Stock Price Today

Edesa Biotech, Inc. (EDSA) is currently trading at $1.20 as of 2026-02-12 14:21:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -1,731.03% over the past four weeks. Over the last 12 months, Edesa Biotech, Inc. has recorded a -35.54% price change, indicating a weak performance relative to the broader market.

Edesa Biotech, Inc. (EDSA) 7-Day Stock Price Changes

Over the past seven days, Edesa Biotech, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $1.10 to the latest recorded price of $1.20, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (331), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, EDSA has delivered a -1,731.03% return over the past month and a -35.54% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Edesa Biotech, Inc. (EDSA)

You can buy and trade EDSA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for EDSA and Execute Your Trade

Open the trading page, enter EDSA in the search bar, select the amount of EDSA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Edesa Biotech, Inc. (EDSA)?

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Edesa Biotech, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	17
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.edesabiotech.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Edesa Biotech, Inc.?

The latest trading price for Edesa Biotech, Inc. (Common Stock) is $ 1.20, compared with a previous closing price of $ 1.07. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for EDSA can be tracked on the live chart and quote section on this page.

2.Is Edesa Biotech, Inc. stock going up or down?

Looking at recent performances, EDSA has returned -1,731.03% over the past month, -47.22% over the last six months and -35.54% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Edesa Biotech, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does EDSA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Edesa Biotech, Inc. has traded between a low of $ 0.94 and a high of $ 4.49. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether EDSA is currently nearer the top or the bottom of its one-year trading band.

4.How is Edesa Biotech, Inc. classified by sector and industry?

Edesa Biotech, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Edesa Biotech, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing EDSA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Edesa Biotech, Inc.’s performance.

5.Where is Edesa Biotech, Inc. listed and how large is it by market value?

Edesa Biotech, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 9.99M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Edesa Biotech, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does EDSA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.86 summarises how much profit Edesa Biotech, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Edesa Biotech, Inc.'s financial performance over time?

To follow Edesa Biotech, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how EDSA is performing and how the market is responding.

8.When is Edesa Biotech, Inc. expected to report earnings?

Edesa Biotech, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for EDSA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Edesa Biotech, Inc.'s earnings reports?

Edesa Biotech, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether EDSA is meeting, beating or missing expectations.

10.How can I stay informed about Edesa Biotech, Inc.'s results and guidance?

You can stay up to date on Edesa Biotech, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for EDSA on this page helps you see how new information is being reflected in the stock.

11.Does Edesa Biotech, Inc. pay a regular cash dividend to its shareholders?

Edesa Biotech, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor EDSA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for EDSA?

Based on the latest earnings data, EDSA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Edesa Biotech, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Edesa Biotech, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Edesa Biotech, Inc.?

Edesa Biotech, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is EDSA valued in terms of P/E ratio and EPS?

Edesa Biotech, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.86. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Edesa Biotech, Inc.'s earnings. Comparing EDSA's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Edesa Biotech, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Argan, Inc.

AGX

Albemarle Corporation

ALB

Amrize Ltd

AMRZ

BlackSky Technology Inc.

BKSY

Cango Inc.

CANG

Top Gainers

Browse today's leading gainers in the US stock market

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

EDSA-to-USD Calculator

Amount

EDSA

USD

1 EDSA = 1.199 USD